{
    "ticker": "AREN",
    "name": "Arena Pharmaceuticals, Inc.",
    "description": "Arena Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on developing innovative therapies to address unmet medical needs in a variety of therapeutic areas including immunology, cardiovascular disease, and central nervous system disorders. Founded in 2000 and headquartered in San Diego, California, Arena is committed to advancing science and improving patient outcomes through the discovery, development, and commercialization of novel drug candidates. The company is best known for its product, Etrasimod, a selective modulator of the sphingosine-1-phosphate (S1P) receptor, which is currently being evaluated in clinical trials for conditions such as ulcerative colitis and Crohn's disease. Arena's pipeline includes several candidates targeting autoimmune diseases, as well as metabolic and pulmonary disorders. With a strong focus on research and development, Arena collaborates with academic institutions and industry partners to accelerate the development of its therapies. The company's mission is to deliver transformative medicines that improve the health and quality of life for patients worldwide.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "San Diego, California, USA",
    "founded": "2000",
    "website": "https://www.arenapharm.com",
    "ceo": "Genevieve M. D. D. O'Connor",
    "social_media": {
        "twitter": "https://twitter.com/arenapharma",
        "linkedin": "https://www.linkedin.com/company/arena-pharmaceuticals"
    },
    "investor_relations": "https://investors.arenapharm.com",
    "key_executives": [
        {
            "name": "Genevieve M. D. D. O'Connor",
            "position": "CEO"
        },
        {
            "name": "Robert E. A. O'Brien",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Therapeutic Products",
            "products": [
                "Etrasimod"
            ]
        }
    ],
    "seo": {
        "meta_title": "Arena Pharmaceuticals, Inc. | Innovative Therapies for Unmet Medical Needs",
        "meta_description": "Explore Arena Pharmaceuticals, Inc., a biopharmaceutical company dedicated to developing innovative therapies for autoimmune, cardiovascular, and central nervous system disorders.",
        "keywords": [
            "Arena Pharmaceuticals",
            "Biotechnology",
            "Pharmaceuticals",
            "Etrasimod",
            "Autoimmune Diseases",
            "Innovative Therapies"
        ]
    },
    "faq": [
        {
            "question": "What is Arena Pharmaceuticals known for?",
            "answer": "Arena Pharmaceuticals is known for developing innovative therapies for autoimmune diseases and other medical conditions, particularly its product Etrasimod."
        },
        {
            "question": "Who is the CEO of Arena Pharmaceuticals?",
            "answer": "Genevieve M. D. D. O'Connor is the CEO of Arena Pharmaceuticals, Inc."
        },
        {
            "question": "Where is Arena Pharmaceuticals headquartered?",
            "answer": "Arena Pharmaceuticals is headquartered in San Diego, California, USA."
        },
        {
            "question": "What are Arena's main products?",
            "answer": "Arena's main product is Etrasimod, which is being developed for various autoimmune diseases."
        },
        {
            "question": "When was Arena Pharmaceuticals founded?",
            "answer": "Arena Pharmaceuticals was founded in 2000."
        }
    ],
    "competitors": [
        "AMGN",
        "ABBV",
        "VRTX",
        "GILD"
    ],
    "related_stocks": [
        "JNJ",
        "PFE",
        "MRNA",
        "BMY"
    ]
}